Table 4.
Secondary end-points: cumulative 1-year major clinical outcomes
| Variable | Entire patients |
Matched patients |
||||
|---|---|---|---|---|---|---|
| Radial (n = 220) | Femoral (n = 469) | p value | Radial (n = 171) | Femoral (n = 171) | p value | |
| Total death | 11 (5.0) | 17 (3.6) | 0.394 | 7 (4.0) | 6 (3.5) | 0.777 |
| Cardiac death | 4 (1.8) | 12 (2.5) | 0.547 | 2 (1.1) | 4 (2.3) | 0.685 |
| Recurrent MI | 0 | 12 (2.5) | 0.012 | 0 | 4 (2.3) | 0.123 |
| STEMI | 0 | 2 (0.4) | NS | 0 | 1 (0.5) | NS |
| NSTEMI | 0 | 10 (2.1) | 0.035 | 0 | 3 (1.7) | 0.248 |
| Revascularizations | 2 (0.9) | 25 (5.3) | 0.005 | 1 (0.5) | 11 (6.4) | 0.003 |
| Target lesion | 2 (0.9) | 17 (3.6) | 0.042 | 1 (0.5) | 6 (3.5) | 0.121 |
| Target vessel | 2 (0.9) | 25 (5.3) | 0.005 | 1 (0.5) | 11 (6.4) | 0.003 |
| Stent thrombosis | 0 | 6 (1.2) | 0.184 | 0 | 1 (0.5) | NS |
| Stoke | 0 | 2 (0.4) | NS | 0 | 2 (1.1) | 0.499 |
| MACE | 13 (5.9) | 45 (9.5) | 0.104 | 8 (4.6) | 20 (11.6) | 0.018 |
Values are presented as number (%). Univariate Cox proportional hazard analysis.
MI, myocardial infarction; STEMI, ST segment elevation MI; NS, not significant (> 0.999); NSTEMI, non-STEMI; MACE, major adverse cardiac event.